Coherus BioSciences

CHRS • NASDAQ • Stock Fundamentals

Coherus BioSciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Dennis Lanfear, with a market cap of $219.0M.

Market Cap$219.0M

Employees306.0

CEODennis Lanfear

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 11, 2026 · 1 month 3 days agoQ1 2026

Next EarningsAug 6, 2026 · in 2 monthsAfter Market Close · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Coherus BioSciences

Coherus BioSciences (CHRS) has a market capitalization of $219.0M and trades on NASDAQ.

Coherus BioSciences has approximately 306 employees.